logo

IMNM

Immunome·NASDAQ
--
--(--)
--
--(--)

IMNM fundamentals

Immunome (IMNM) released its earnings on Aug 6, 2025: revenue was 4.01M (YoY +69.84%), beat estimates; EPS was -0.5 (YoY +16.67%), beat estimates.
Revenue / YoY
4.01M
+69.84%
EPS / YoY
-0.5
+16.67%
Report date
Aug 6, 2025
Earnings Call
9:30 AM on Aug 6, 2025
Meeting link.
EPS
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.4-0.37-0.46-0.65-0.65-0.96-0.74-0.75-0.64-0.35-0.46-0.36-4.21-2.51-0.6-0.78-1.11-0.52-0.5
Forecast
-0.29-0.41-0.39-0.505-0.81-0.69-0.93-0.76-0.6750.585-0.16-0.17-0.2733-0.68-0.3794-0.5514-0.6408-0.6348-0.5167
Surprise
-37.93%
+9.76%
-17.95%
-28.71%
+19.75%
-39.13%
+20.43%
+1.32%
+5.19%
-159.83%
-187.50%
-111.76%
-1440.43%
-269.12%
-58.14%
-41.46%
-73.22%
+18.08%
+3.23%
Revenue
Q4,2020
Q1,2021
Q2,2021
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
----000----0--2.36M4.26M3.56M3.84M1.03M2.36M2.91M2.74M2.93M4.01M
Forecast
2.10M000000000002.07M2.80M1.87M2.29M3.15M783.26K833.33K
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
+85.71%
-63.25%
+26.64%
+27.12%
-12.90%
+273.56%
+381.80%

Earnings Call